NTXBIO

Live / Registered — Registered (as of 21 Jan 2020)

What this means for you

Registered since 21 Jan 2020. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
87899061
Registration number
5968169
Mark type
Stylized text
Filed
28 Apr 2018
Published for opposition
09 Apr 2019
Registered
21 Jan 2020
Attorney of record
David Kerr

Goods and services

  • Class 040 — Treatment of materials: Custom manufacturer of pharmaceutical and biopharmaceutical compounds, namely, antibiotics, proteins, vaccines, enzymes, and small molecules
  • Class 042 — Scientific and technological services: Research and development of pharmaceuticals, therapeutics, and biologics, namely, vaccines, antibiotics, vaccines generated in a cell-free protein synthesizing system, antibiotics generated in a cell-free protein synthesizing system, proteins generated in a cell-free protein synthesizing system, and enzymes generated in a cell-free protein synthesizing system; research and development in the field of bioinformatics and production of proteins in cell-free systems for the development of vaccines, and antibiotics; medical research and development in the field of synthetic biology, molecular biology, genetic engineering and bioinformatics; research and development of new drug compounds for therapeutic use; research and development of new biological products for therapeutic use; research and development of antibiotic compounds for therapeutic use; research and development of methods of high-throughput screening of biological materials; research and development of methods of rapid-prototyping of biological materials; research and development of methods of real-time metabolic profiling of bacteria, fungi and plants to discover, characterize and produce bioactive products; design and development of nucleic acids, proteins, enzymes, antibiotic compounds, and drug compounds for use in pharmaceuticals, biotechnology, and medical and diagnostic applications using predictive bioinformatics; bioinformatics scientific research services, namely, identifying new drug compounds from analysis of genomic data

Owner

Prosecution history

  • 21 Jan 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
  • 23 Oct 2024 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
  • 09 Dec 2020 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
  • 21 Jan 2020 — REGISTERED-PRINCIPAL REGISTER
  • 17 Dec 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 16 Dec 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 10 Dec 2019 — STATEMENT OF USE PROCESSING COMPLETE
  • 03 Dec 2019 — USE AMENDMENT FILED
  • 10 Dec 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 03 Dec 2019 — TEAS STATEMENT OF USE RECEIVED
  • 04 Jun 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 09 Apr 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 09 Apr 2019 — PUBLISHED FOR OPPOSITION
  • 20 Mar 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 27 Feb 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER

View this trademark record on Marksy